-+ 0.00%
-+ 0.00%
-+ 0.00%

BioAtla Q3 EPS $(0.27) Beats $(0.30) Estimate

Benzinga·11/13/2025 21:10:34
Listen to the news
BioAtla (NASDAQ:BCAB) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.30) by 9.09 percent. This is a 22.73 percent decrease over losses of $(0.22) per share from the same period last year.